For thirty years, the supplement aisle has sold fish oil as one of the simplest decisions you can make for your brain. In 2026, two research teams on opposite sides of the world published papers that complicate that story, and the literature behind them has been building for almost twenty years.

IN THIS INVESTIGATION

• What a 2026 ADNI cohort study of 800+ older adults actually found
• Why faster cognitive decline in fish oil users showed up on every measure
• What the brain imaging revealed when classic Alzheimer's pathology came back negative
• The 2026 Cell Reports mechanism work in repetitive brain injury
• Why EPA and DHA do different things inside the brain, and why most trials ignored the difference
• Twenty years of cognitive trials nobody connected, including a 2006 trial whose biomarkers, re-analyzed in 2021, told a different story
• What the 2026 authors themselves said about how to read their own findings
• Dose, baseline status, oil quality, and physiological context; the conditions the supplement aisle has never asked about
• What twenty years of brain literature actually supports if you take fish oil today

Subscribe for more investigations.